Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIGBIO Herlev ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.8% 2.8%   Bankruptcy risk   1.0% 0.9% 1.4% 0.8% 0.6% 0.7% 9.0% 8.8%   Credit score (0-100)   88 89 78 91 96 92 27 28   Credit rating   A A A AA AA AA BB BB   Credit limit (kDKK)   865.3 841.3 94.9 1,175.8 2,552.8 1,416.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   16,851 17,373 9,471 10,184 15,764 10,892 0.0 0.0   EBITDA   7,831 7,584 1,508 3,781 9,103 3,180 0.0 0.0   EBIT   6,959 6,574 413 2,745 7,746 1,949 0.0 0.0   Pre-tax profit (PTP)   6,960.0 6,742.2 491.7 2,819.0 7,886.7 2,421.2 0.0 0.0   Net earnings   5,416.1 5,248.6 381.5 2,198.0 6,150.3 1,881.5 0.0 0.0   Pre-tax profit without non-rec. items   6,960 6,742 492 2,819 7,887 2,421 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   5,047 4,759 3,764 3,457 2,100 870 0.0 0.0   Shareholders equity total   6,378 6,627 7,008 9,206 15,357 11,238 4,658 4,658   Interest-bearing liabilities   10.4 639 1.3 3.1 0.2 925 0.0 0.0   Balance sheet total (assets)   13,653 14,271 14,506 16,574 24,476 17,665 4,658 4,658   Net Debt   -5,024 372 -3,325 -3,302 -9,978 -1,911 -4,658 -4,658     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   16,851 17,373 9,471 10,184 15,764 10,892 0.0 0.0   Gross profit growth   -2.1% 3.1% -45.5% 7.5% 54.8% -30.9% -100.0% 0.0%   Employees   18 19 18 18 18 18 0 0   Employee growth %   -5.3% 5.6% -5.3% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   13,653 14,271 14,506 16,574 24,476 17,665 4,658 4,658   Balance sheet change%   -3.5% 4.5% 1.6% 14.3% 47.7% -27.8% -73.6% 0.0%   Added value   7,831.0 7,583.6 1,508.3 3,780.5 8,781.8 3,180.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,893 -1,298 -2,090 -1,342 -2,714 -2,461 -870 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   41.3% 37.8% 4.4% 27.0% 49.1% 17.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   50.3% 48.5% 3.6% 18.4% 38.5% 11.7% 0.0% 0.0%   ROI %   99.2% 96.0% 7.2% 35.2% 64.4% 17.9% 0.0% 0.0%   ROE %   84.4% 80.7% 5.6% 27.1% 50.1% 14.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.9% 50.7% 53.6% 59.6% 64.7% 67.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -64.2% 4.9% -220.5% -87.3% -109.6% -60.1% 0.0% 0.0%   Gearing %   0.2% 9.6% 0.0% 0.0% 0.0% 8.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.3% 7.0% 9.1% 1,697.9% 1,539.0% 7.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.3 1.6 2.0 2.6 2.9 0.0 0.0   Current Ratio   1.1 1.2 1.3 1.8 2.5 2.6 0.0 0.0   Cash and cash equivalent   5,034.1 267.4 3,326.7 3,304.6 9,978.0 2,835.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   794.9 1,345.5 2,560.0 5,749.2 13,256.3 10,368.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   435 399 84 210 488 177 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   435 399 84 210 506 177 0 0   EBIT / employee   387 346 23 153 430 108 0 0   Net earnings / employee   301 276 21 122 342 105 0 0